Precedence Research’s latest report on the global pharmaceutical manufacturing market provides an analysis for the period of 2017 to 2030, wherein, 2020 is the base year, 2017 and before is historical data, and 2021 to 2030 is the forecast period.
The global pharmaceutical manufacturing market size was valued at US$ 357.9 Billion in 2020 and is projected to reach US$ 1,173.3 Billion by 2030, rising at a market growth (CAGR) of 12.8% during the forecast period.
Precedence Research provides an in-depth analysis of market size, share analysis, Industry growth, market valuation, market dynamics which includes drivers, restraints, opportunities, trends, challenges, market segmentation, competitive landscape, regional and country breakdowns, and strategies for pharmaceutical manufacturing market. The study reviews the global industry by-products or services offered, downstream fields, end using customers, historic data figures regarding revenue and sales, market context, and more.
The report comprises a detailed value chain analysis, which provides a comprehensive view of this market. The Porter’s Five Forces model for the global market has also been included to help understand the competitive landscape. The study covers market attractiveness analysis, wherein resin types are benchmarked based on their market value, growth rate, and general attractiveness.
Download FREE SAMPLE PAGES before Purchase @ https://www.precedenceresearch.com/sample/1191
The pharmaceutical business is a vital segment of the larger healthcare ecosystem. The pharmaceutical industry primarily deals with scientific research activities and the development of medications that avert or treat ailments and disorders. The pharmaceutical industry comprises of both private as well as public establishments that conceive, promote, produce, and retail medicines. Modern technological and scientific breakthroughs are speeding up the detection and development of innovative medications or treatments with improved healing activity and less side effects. Medicinal chemists, molecular biologists, and pharmacists work collectively for enhancing the quality and efficiency of the drugs. Pharmaceutical manufacturing is the procedure of commercial-scale creation of medicines by pharmaceutical establishments.
The growing demand for modernization of pharmaceutical manufacturing process has prompted leading companies to employ new technologies such as continuous pharmaceutical manufacturing. This technology offers probable flexibility, superiority, and economic rewards over batch processing, together in process manufacturing and expansion for the pharmaceutical sector. Since the past few years, there have been significant advancements in science and engineering to support the implementation of continuous pharmaceutical manufacturing. These advancements, together with the acceptance of the QbD paradigm for pharmaceutical progress and the development of PAT for designing, examining, and controlling production, have advanced the scientific and monitoring eagerness for continuous manufacturing.
Factors such as increasing prevalence of chronic ailments, growing geriatric population, high investment in research and development, increasing focus on outsourcing manufacturing activities, increasing per capita healthcare expenditure, growing incidence of novel viral diseases, technological advancements in manufacturing processes, and improving reimbursement scenario in developing regions are driving the growth of pharmaceutical manufacturing market. Amplified focus on elderly and pediatric patients, high incidence of cardiovascular disorders, growing demand for home-based healthcare, and increased cancer and diabetes cases are further propelling the pharmaceutical manufacturing market expansion across the globe. Additional aspects that are anticipated to fuel this industry are increasing demand for new drug delivery approaches and reformulation of injections and oral medications.
The pharmaceutical industry is predominantly motivated by scientific advancements, in combination with clinical and toxicological experience. Major variances exist between large establishments and smaller organizations. Large pharmaceutical companies participate in an extensive range of medicine discovery and development, production and quality control, promotion and sales, whereas small pharmaceutical companies focus on a precise aspect.
The report covers data for North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. In 2019, North America dominated the global market with a market share of more than 41%. U.S. signified the highest portion in the North American region largely due to large investment in pharmaceutical research and development and presence of skilled researchers. Furthermore, early implementation of latest therapies also contributed to the high market share of the United States.
Europe was the next important market mainly due to encouraging reimbursement scenario and high investment in research and development. The presence of leading companies in the European region is also expected to boost the demand for pharmaceutical manufacturing in the projected time-span. Asia Pacific is estimated to advance at the maximum CAGR of around 15.8% in the forecast period due to high incidence of chronic ailments. Middle East, Africa and Latin American region will exhibit noticeable progress.
- Among the drug development type segment, in-house drug development is expected to dominate the overall market. The use of in-house drug development capabilities by large pharmaceutical companies for securing the crucial information is a major reason for the high market share of in-house segment.
- The oral route of administration accounted for the largest revenue in the containers segment with more than 68% share in 2020. Affordability, ease of use and storage are the major reason for high market share of oral route of administration. Parenteral segment is expected to grow at the topmost CAGR during the forecast time-frame.
- Tablets accounted for the largest revenue in the formulation segment. Widespread availability of tablets is the key reason for high market share.
- Cancer accounted for the largest revenue in the therapy segment. High incidence of cancer globally and heavy investment in research and development for developing effective cancer therapies are the key reasons for high market share.
- F. Hoffmann-La Roche Ltd., Novartis AG, and Pfizer, Inc. accounted for a significant share of the global pharmaceutical manufacturing market.
Key Players of the global pharmaceutical manufacturing market are:
- GlaxoSmithKline plc
- Merck & Co., Inc.
- Eli Lilly and Company
- Johnson & Johnson
- Hoffmann-La Roche Ltd.
- Pfizer, Inc.
- Sanofi SA
- Novartis AG
Segments Covered in the Report:
By Drug Development Type
By Route of Administration
- Cardiovascular Diseases
- Respiratory Diseases
- North America (United States, Canada)
- Europe (Germany, France, UK, Italy, Russia, and Rest of Europe)
- Asia-Pacific (China, Japan, India, Southeast Asia, Korea, and Rest of Asia Pacific)
- Latin America (Brazil and the Rest of Latin America)
- The Middle East and Africa (GCC, North Africa, South Africa, and Rest of the Middle East & Africa)
Purchase this Market Research Report @ https://www.precedenceresearch.com/checkout/1191
Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semiconductors, chemicals, automotive, and among different ventures present globally.
Call: +1 9197 992 333
Carolina is an author who specializes in covering healthcare, chemical, and the automotive industry. Before joining Market Stats News, Carolina covered some of the biggest companies in Silicon Valley for the San Jose Mercury News. She loves all things French and the written word. Articles by Carolina